Conformis Inc
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $62.0M | $99.9M | $68.8M | $20.6M | $19.7M | $20.5M |
| Operating income | −$46.3M | −$3.0M | −$25.1M | −$25.1M | −$38.7M | −$55.8M |
| Net income | −$50.5M | −$2.4M | −$24.3M | −$7.6M | −$12.0M | −$17.2M |
| Total assets | $94.0M | $145.3M | $71.5M | $72.4M | $63.0M | $93.8M |
| Total liabilities | $39.9M | $44.8M | $60.1M | $56.0M | $26.8M | $47.3M |
| Equity | $54.2M | $100.6M | $11.4M | $16.3M | $36.2M | $46.5M |
| EPS (diluted) | $-6.99 | $-0.36 | $-0.34 | $-0.44 | $-0.74 | $-1.24 |
| Shares out. | 185.6M | 182.6M | 71.6M | 67.9M | 60.9M | 43.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −74.6%
- Net margin
- −81.3%
- Return on equity
- −93.2%
- Return on assets
- −53.7%
- Return on capital (ROCE)
- −57.9%
- Liabilities / assets
- 42.4%
- Debt / equity
- 0.74×
- Book value / share
- $0.29
- Revenue growth (YoY)
- −37.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -17.48distress
- Accruals / assets
- −0.3%clean
- Beneish M-Score
- -1.90normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 5, 2023
- Shareholder voteAug 31, 2023
- Results of operationsAug 2, 2023
- Entered a material agreement · Other material eventJun 23, 2023
- Director / officer changeMay 19, 2023
- Director / officer change · Shareholder voteMay 10, 2023
- Results of operations · Director / officer changeMay 8, 2023
- Results of operationsMar 1, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.